Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prometheus Biosciences Inc
(NQ:
RXDX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 15, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prometheus Biosciences Inc
< Previous
1
2
3
4
5
Next >
Analyst Expectations for Prometheus Biosciences's Future
March 01, 2023
Via
Benzinga
Prometheus Biosciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Progress
February 28, 2023
From
Prometheus Biosciences
Via
GlobeNewswire
Prometheus Biosciences Announces Two Oral Presentations on PRA023 at the 18th Congress of European Crohn’s and Colitis Organisation (ECCO)
February 22, 2023
From
Prometheus Biosciences
Via
GlobeNewswire
Prometheus Biosciences to Present at the SVB Securities Global Biopharma Conference
February 09, 2023
From
Prometheus Biosciences
Via
GlobeNewswire
Analyst Expectations for Prometheus Biosciences's Future
January 31, 2023
Via
Benzinga
Looking Into Prometheus Biosciences's Return On Capital Employed
December 16, 2022
Via
Benzinga
Where Prometheus Biosciences Stands With Analysts
December 08, 2022
Via
Benzinga
How Is The Market Feeling About Prometheus Biosciences?
January 04, 2023
Prometheus Biosciences's (NASDAQ:RXDX) short percent of float has fallen 35.76% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 8.3% of all...
Via
Benzinga
Prometheus Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Prometheus Biosciences
Via
GlobeNewswire
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
December 31, 2022
2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
December 23, 2022
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Why Prometheus Biosciences Stock Is Falling
December 09, 2022
Prometheus Biosciences Inc (NASDAQ: RXDX) shares are trading lower by 6.01% to $110.16 going into the close of Friday's session after the company priced a public upsized $500 million offering.
Via
Benzinga
Is Prometheus Biosciences a Good Stock to Buy Right Now?
December 09, 2022
This biotech stock just jumped over 180% in a single day, and investors want to know if there could be more big gains ahead.
Via
The Motley Fool
Prometheus Biosciences, Inc. Announces Pricing of Public Upsized $500 Million Offering of Common Stock
December 08, 2022
From
Prometheus Biosciences
Via
GlobeNewswire
Why Prometheus Biosciences Stock Is Rocketing Higher Today
December 08, 2022
Prometheus Biosciences Inc (NASDAQ: RXDX) shares are trading higher Thursday after multiple analyst firms raised price targets on the stock following positive results from the company's PRA023 in both
Via
Benzinga
Analyzing Prometheus Biosciences's Short Interest
December 08, 2022
Prometheus Biosciences's (NASDAQ:RXDX) short percent of float has risen 5.39% since its last report. The company recently reported that it has 4.89 million shares sold short, which is 13.3% of all...
Via
Benzinga
Why Shares of Prometheus Biosciences Are Soaring This Week
December 08, 2022
The clinical-stage biotech that specializes in IBD therapies announced positive news regarding two trials for its lead therapy.
Via
The Motley Fool
Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
December 08, 2022
Via
Benzinga
Tesla, Apple, GameStop, Prometheus Biosciences, Cassava Sciences: Why These 5 Stocks Are Drawing Investors' Attention Today
December 07, 2022
U.S. markets continued their weak trend on Wednesday, with next week’s Federal Open Market Committee meeting beginning to weigh on investors’ minds.
Via
Benzinga
Biotechs Race for New Treatments as Breast Cancer Therapeutics Market Could Reach $15 Billion by 2028
December 08, 2022
EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NYSE:BMY),(NASDAQ:RXDS),(NASDAQ:RNAZ) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Prometheus Biosciences, Inc. Announces Proposed Public Offering of Common Stock
December 07, 2022
From
Prometheus Biosciences
Via
GlobeNewswire
Dow Edges Higher; Prometheus Biosciences Shares Jump
December 07, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 0.5% on Wednesday.
Via
Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 07, 2022
Via
Benzinga
Prometheus Biosciences (NASDAQ: RXDX) Reports PRA023 Candidate Achieved Positive Results in Both its ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Clinical Trials
December 07, 2022
Prometheus Biosciences, Inc. (NASDAQ: RXDX) is engaged as a clinical-stage biotechnology company, which is focused on the research, development and
Via
Spotlight Growth
Nasdaq Drops 75 Points; Crude Oil Down 2%
December 07, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping 75 points on Wednesday.
Via
Benzinga
Dow Bounces Back From Morning Selloff
December 07, 2022
The Dow Jones Industrial Average is trying to claw back from the market's multi-day selloff. Meanwhile, the S&P 500 Index and Nasdaq Composite Index continue to flag near breakeven.
Via
Talk Markets
PINS Stock Alert: What to Know as Pinterest and Elliott Strike a Deal
December 07, 2022
Pinterest (PINS) stock is on the move Wednesday as investors react to an agreement with Elliott Investment Management L.P.
Via
InvestorPlace
US Stocks Mixed; Dow Rises 50 points
December 07, 2022
U.S. stocks traded mixed this morning, with the Dow Jones gaining more than 50 points on Wednesday.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.